Natick, MA, United States of America

Danny LaFrance

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 4.3

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2018-2025

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Danny LaFrance

Introduction

Danny LaFrance is a notable inventor based in Natick, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly through his work on crystalline forms of eravacycline. With a total of five patents to his name, LaFrance has established himself as a key figure in pharmaceutical innovation.

Latest Patents

LaFrance's latest patents focus on the crystalline forms of the bis-HCl salt of a compound represented by Structural Formula 1. These inventions include pharmaceutical compositions that incorporate these crystalline forms, specifically Forms I, J, A, and B. The compositions are designed to treat various disorders, showcasing the potential therapeutic applications of his work. Additionally, methods for preparing these crystalline forms are also described, further emphasizing the practical implications of his inventions.

Career Highlights

Danny LaFrance is currently associated with Tetraphase Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work has been instrumental in enhancing the understanding and application of eravacycline in medical treatments.

Collaborations

LaFrance has collaborated with notable colleagues such as Philip C Hogan and Yansheng Liu. These partnerships have contributed to the successful development of his innovative pharmaceutical solutions.

Conclusion

Danny LaFrance's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a leading inventor. His work continues to impact the treatment of various disorders, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…